Nanjing Vazyme Biotech Co., Ltd., a biotechnology company, engages in the research, development, and production of enzymes, antigens, antibodies, and polymer organic materials. The company offers scientific research reagents, such as PCR clone point mutation, nucleic acid extraction, reverse transcription, qPCR, cell/protein, gene editing series, and instant granules; high-throughput sequencing library construction reagents, including DNA and RNA library, single cell epigenetic, magnetic, quantitative series, and cell-free DNA storage and extractions; and biomedical reagents and services. It serves scientific research institutions, high-throughput sequencing service companies, molecular diagnostic reagent manufacturers, pharmaceutical companies, CRO companies, hospitals, and other medical institutions. The company was founded in 2012 and is based in Nanjing, China.
Nanjing Vazyme Biotech Dividend Announcement
• Nanjing Vazyme Biotech announced a annually dividend of ¥0.10 per ordinary share which will be made payable on 2024-07-08. Ex dividend date: 2024-07-08 • Nanjing Vazyme Biotech annual dividend for 2024 was ¥0.10 • Nanjing Vazyme Biotech annual dividend for 2023 was ¥1.25 • Nanjing Vazyme Biotech's trailing twelve-month (TTM) dividend yield is 0.36% • Nanjing Vazyme Biotech's payout ratio for the trailing twelve months (TTM) is 263.18%
Nanjing Vazyme Biotech current trailing twelve-month (TTM) dividend yield is 0.36%. Interested in purchasing Nanjing Vazyme Biotech stock? Use our calculator to estimate your expected dividend yield:
Nanjing Vazyme Biotech Financial Ratios
P/E ratio466.95
PEG ratio1.52
P/B ratio2.80
ROE0.59%
Payout ratio263.18%
Current ratio4.69
Quick ratio4.17
Cash Ratio0.10
Nanjing Vazyme Biotech Dividend FAQ
How much is the next Nanjing Vazyme Biotech dividend?
Nanjing Vazyme Biotech's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next Nanjing Vazyme Biotech dividend. The next Nanjing Vazyme Biotech dividend will be released in June.
When is Nanjing Vazyme Biotech dividend paid?
Nanjing Vazyme Biotech pays dividends on a annually basis. The specific dates may vary each year but are generally around June. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does Nanjing Vazyme Biotech pay?
The specific amount of Nanjing Vazyme Biotech dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Nanjing Vazyme Biotech's dividend history.
Does Nanjing Vazyme Biotech stock pay dividends?
Yes, Nanjing Vazyme Biotech does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Nanjing Vazyme Biotech's dividend history.
How much dividend does Nanjing Vazyme Biotech pay?
Nanjing Vazyme Biotech paid ¥0.1 in 2024, ¥1.25 in 2023, ¥0.3 in 2022, ¥0.0 in 2021, and ¥0.0 in 2020.
How often does Nanjing Vazyme Biotech pay dividends?
Nanjing Vazyme Biotech typically pays dividends on a annually basis. This means that dividends are usually distributed 1 times a year. The specific payout dates may vary each year but generally fall around June.
What is Nanjing Vazyme Biotech's dividend yield?
The current dividend yield for Nanjing Vazyme Biotech is 0.36%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate Nanjing Vazyme Biotech's exact dividend yield.
When does Nanjing Vazyme Biotech go ex dividend?
Nanjing Vazyme Biotech's ex-dividend date for the latest dividend was on 2024-07-08. Nanjing Vazyme Biotech typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next Nanjing Vazyme Biotech dividend paid?
Nanjing Vazyme Biotech pays dividends on a annually basis, typically around June, but the exact dates can vary each year.
Will Nanjing Vazyme Biotech increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether Nanjing Vazyme Biotech will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is Nanjing Vazyme Biotech dividend per share?
Nanjing Vazyme Biotech paid ¥0.1 per share in 2024 and ¥1.25 per share in 2023. The amount of dividend per share that Nanjing Vazyme Biotech pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is Nanjing Vazyme Biotech a dividend aristocrat?
No, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Nanjing Vazyme Biotech a dividend king?
No, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Nanjing Vazyme Biotech a dividend stock?
Yes, Nanjing Vazyme Biotech is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is Nanjing Vazyme Biotech a good dividend stock?
Whether Nanjing Vazyme Biotech is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. Nanjing Vazyme Biotech has a history of paying regular dividends, which can make it attractive to income-focused investors.
Other factors to consider when evaluating Nanjing Vazyme Biotech as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does Nanjing Vazyme Biotech pay dividends monthly?
Nanjing Vazyme Biotech typically pays dividends on a annually basis.
Does Nanjing Vazyme Biotech pay dividends quarterly?
Nanjing Vazyme Biotech currently pays dividends on a annually basis.
Has Nanjing Vazyme Biotech ever paid a dividend?
Yes, Nanjing Vazyme Biotech has a history of paying dividends to its shareholders. Nanjing Vazyme Biotech is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy Nanjing Vazyme Biotech dividend stocks?
To buy Nanjing Vazyme Biotech you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.
Place an order: Use the brokerage's trading platform to place an order to buy Nanjing Vazyme Biotech stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does Nanjing Vazyme Biotech pay dividends 2024?
Nanjing Vazyme Biotech pays dividends on a annually basis. 2024 dividend payments are in 2024-07-08. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will Nanjing Vazyme Biotech increase its dividend in 2024?
Decisions regarding Nanjing Vazyme Biotech dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date Nanjing Vazyme Biotech dividend overview you can look into the above table of dividend history.
How Nanjing Vazyme Biotech dividend works?
The Nanjing Vazyme Biotech dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how Nanjing Vazyme Biotech's dividend process works:
1. Determination of Dividend: Nanjing Vazyme Biotech's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Nanjing Vazyme Biotech publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Nanjing Vazyme Biotech distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Nanjing Vazyme Biotech are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are Nanjing Vazyme Biotech dividends paid?
Nanjing Vazyme Biotech dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:
1. Record Date: Nanjing Vazyme Biotech sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Nanjing Vazyme Biotech distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Nanjing Vazyme Biotech declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does Nanjing Vazyme Biotech pay dividends?
Nanjing Vazyme Biotech typically pays dividends on a annually basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does Nanjing Vazyme Biotech pay dividends?
The general pattern is that Nanjing Vazyme Biotech pays dividends around June. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is Nanjing Vazyme Biotech dividend safe?
The safety of Nanjing Vazyme Biotech's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.
To assess the safety of Nanjing Vazyme Biotech's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Nanjing Vazyme Biotech's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.